SPARK-ALL: Calaspargase Pegol in Adults With ALL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel J. DeAngelo, MD, PhD
Dana-Farber Cancer Institute, Boston, MA
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Honorhealth Cancer Transplant Institute
Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Univeristy of California
Los Angeles, California, United States
- University of California Irvine Health (uci Health)
Orange, California, United States
- University of Miami Health System - Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- University of Chicago Medicine
Chicago, Illinois, United States
- University of Kansas Cancer Center - Richard and Annette Bloch Cancer Care Pavilion
Westwood, Kansas, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- University of Maryland Greenbaum Cancer Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Weymouth, Massachusetts, United States
- Northwell Health Cancer Institute
Lake Success, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Nyu Langone/laura and Isaac Perlmutter Cancer Center
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health & Science University (ohsu)
Portland, Oregon, United States
- Jefferson Health
Philadelphia, Pennsylvania, United States
- Baptist Clinical Research Institute
Memphis, Tennessee, United States
- Intermountain Healthcare (ihc)
Salt Lake City, Utah, United States
- University of Washington/seattle Cancer Care Alliance/fred Hutch
Seattle, Washington, United States
- West Virginia University Cancer Institute
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Jul 2021
- Primary completion
- 21 Mar 2025
- Completion
- 21 Mar 2025
- Last update posted
- 18 Feb 2026
- Registered enrollment
- 42
- Registry id
- NCT04817761
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.